Haier Biomedical Approved By U.S. R&D Institutions

 Breaking News
  • No posts were found

Haier Biomedical Approved By U.S. R&D Institutions

Winning Recognition in the U.S. Market with Innovation & Technology, Haier Biomedical Continues to Demonstrate Its International Capability.

With the new variant emerging in several countries around the world, new initiatives have been taken to fight the pandemic. The U.S. announced on December 2nd new anti-pandemic initiatives to protect Americans from the mutated virus this winter. The new initiative will provide booster vaccines for all adults, continue to guarantee the vaccination of children, and contribute to global vaccination efforts.

The new anti-pandemic initiative has mentioned vaccination many times, reflecting the high level of attention paid to the latest research and development of vaccines and antiviral drugs. To meet the strict temperature and safe storage requirements of precious biological samples needed in vaccine research and antiviral drug development, the Johns Hopkins University and the U.S. Centers for Disease Control and Prevention have successively introduced Haier Biomedical’s ULT Freezer to provide a safe, secure, and reliable storage environment for precious research samples and promote local vaccine research and other life science research work.

Entering the top research universities to assist in the development of anti-pandemic research

The Johns Hopkins University is the first research university in the United States and one of the 14 founding schools of the Association of American Universities (AAU), the academic alliance of top universities in North America. In order to better promote the national anti-pandemic process and research the newly emerged variant and the corresponding vaccine, Johns Hopkins University chose Haier Biomedical’s ULT Freezer DW-86L728ST to assist in its subsequent scientific research.

The dual system ULT Freezer from Haier Biomedical is known for its safety. It has two independent freezing systems, if one of them has problems, the other will automatically run and maintain the storage temperature of -80 ℃, providing the highest level of protection for valuable samples that require strict and continuous storage conditions. In addition, the product adopts a hydrocarbon refrigeration system, which can achieve rapid cooling, and its energy-saving efficiency is 50% higher than the traditional refrigeration technology, greatly reducing the cost per unit of sample storage. And the application of VIP insulation technology makes the insulation efficiency increase by 20% on the original basis. The products are recognized by the market in terms of performance, environmental protection, and energy-saving.

Trusted by U.S. government agency as a long-term partner

The Centers for Disease Control and Prevention (hereinafter referred to as CDC) is a government agency under the U.S. Department of Health and Human Services and the first federal health organization created in the United States. Currently, the Center’s main task is to prevent and control infectious diseases, and it plays an important role in the prevention and control of the COVID-19 pandemic.

As a global supplier and manufacturer of complete cold chain solutions, Haier Biomedical continues to pay attention to the global pandemic. With stable product performance and superior quality, Haier Biomedical has signed a 5-year long-term procure agreement with the US CDC. At present, Haier Biomedical’s ULT Freezer DW-86L579BPT has arrived at the destination.

As part of the complete cold chain solutions, Haier Biomedical’s ULT Freezer has reached a world-leading level of energy efficiency, insulation, safety and stability, bringing a more stable and efficient sample storage solution for scientific research, thus being highly recognized by the U.S. market. The frequent presence of Haier Biomedical products in major top institutions in the United States is a sign of Haier Biomedical’s increasing competitiveness in developed markets like the United States and reflects the global market’s recognition and trust in Haier Biomedical.

Media Contact
Company Name: Haier Biomedical
Email: Send Email
Phone: +86-532-88935593
Country: China
Website: https://www.haiermedical.com/